Technologies for the transportation of cannabidiol (CBD) and cannabigerol (CBG) derivatives, as well as other phytocannabinoids.
What are the
Phytocannabinoids are natural lipophilic terpenophenolic compounds and their transformation products are obtained from the genus Cannabis.
i+Med’s phytocannabinoid technology is based on the encapsulation of actives in water-soluble micro and nanoparticles
Our know-how and 2 patents allow the work with phytocannabinoids in different encapsulation systems.
These systems can be combined with biopolymeric macrogels, hydrogel-based coatings and other matrix systems that allow their use in biocompatible formulations and the control of their bioavailability.
This allows the generation of solid ingredients easily soluble in water, as well as the possibility of formulating solutions, gels and topical lotions on a water-based basis.
Presentation and use
The formulation of sterile products in aqueous phase allows the manufacture of parenteral products
Use of aqueous phases for the topical application of phytocannabinoids without resorting to emulsions
Generation of tablets, capsules and liquids for oral administration in aqueous medium, increasing its bioavailability
Generation of stable solid ingredients for use in the preparation of aqueous formulations high in phytocannabinoids.
The coating technology allows the release of phytocannabinoids from the implant itself by modifying the bioavailability and its lifetime.
Formulation for nasal route in spray forms to increase the bioavailability of the therapeutic properties of phytocannabinoids.